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RNA-Seq identifies genes whose 
proteins are transformative in the 
differentiation of cytotrophoblast 
to syncytiotrophoblast, in 
human primary villous and BeWo 
trophoblasts
Christopher Azar1, Mark Valentine2, Julie Trausch-Azar1, Todd Druley1,2, D. Michael Nelson3 & 
Alan L. Schwartz1,4
The fusion of villous cytotrophoblasts into the multinucleated syncytiotrophoblast is critical for the 
essential functions of the mammalian placenta. Using RNA-Seq gene expression and quantitative 
protein expression, we identified genes and their cognate proteins which are coordinately up- or down-
regulated in two cellular models of cytotrophoblast to syncytiotrophoblast development, human 
primary villous and human BeWo cytotrophoblasts. These include hCGβ, TREML2, PAM, CRIP2, INHA, 
FLRG, SERPINF1, C17orf96, KRT17 and SAA1. These findings provide avenues for further understanding 
the mechanisms underlying mammalian placental synctiotrophoblast development.
The mammalian placenta is a specialized organ that serves essential roles in fetal growth and development 
throughout pregnancy including regulated delivery of nutrients to the fetus and elimination of metabolic wastes, 
regulated gas exchange and secretion of hormones that maintain pregnancy. Placental dysfunction underlies both 
short-term (e.g. fetal growth restriction) and long-term (e.g. consequences of developmental origins of adult 
disease) sequelae for the fetus-newborn-child-adult.
The syncytiotrophoblast of term placenta is a multinucleated, continuous layer surfacing of villi. The subjacent, 
proliferative villous cytotrophoblasts replenish the overlying syncytiotrophoblast through membrane–membrane 
fusion events. Importantly, the mechanisms that govern the transition of villous cytotrophoblasts into syncy-
tiotrophoblast are central to understanding the physiological and pathological roles of this key maternal-fetal 
interface.
The fusion of cytotrophoblasts is tightly regulated, as reflected by the constancy of the 9/1 ratio of nuclei 
in villous syncytiotrophoblast compared to cytotrophoblasts from the first to third trimesters of pregnancy1. 
The processes that regulate villous cytotrophoblast fusion with syncytiotrophoblast are largely unknown, but 
pathways to multinucleated syncytia are better understood in myoblast cell-cell fusion2. For example, myoblast 
fusion in Drosophila involves a two-component process that signals through multiple pathways to effect actin 
cytoskeleton rearrangement with receptor-mediated membrane juxtaposition which is followed by membrane 
destabilization3. Moreover, recent studies in mammalian myoblast fusion identified key regulators of this pro-
cess, including ferlin, myomaker, and myomixer4–7. Mediators identified to associate with cytotrophoblast fusion 
include syncytin-1, syncytin-2, SLC1A5, MFSD2A, galectin-1, transglutaminase 2-dependent deamidation of 
G3PD, and intermediate conductance Ca2+ activated channels8–14. Best studied among these are syncytin-1 and 
syncytin-2, which are fusogenic Env glycoproteins of human endogenous retroviral origin. Initially identified by 
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Mi et al.14 and Blond et al.9, syncytin-1 is a member of the HERV-W family and confers the capacity for homo- 
and heterotypic fusion when expressed in cell lines expressing the syncytin-1 receptor SLC1A513. Knockout of the 
murine syncytin-1 (i.e. syncytin-A) results in defective placental structure, which includes an absent labyrinth, 
excess unfused cytotrophoblasts, and embryonic lethality at 11.5-13.5 dpc15. Yet, the presence of syncytin-1 and 
its receptor in human cytotrophoblast cell lines is, in itself, insufficient for trophoblast fusion16,17. Thus, additional 
critical components of the fusion machinery must exist.
Villous cytotrophoblasts isolated from term human placentas undergo differentiation and fusion into syncytia 
during culture18,19. Moreover, a cloned cell line, BeWo b3020., was derived from the parental human trophoblast 
choriocarcinoma BeWo, and is responsive to signals for cell fusion. Indeed, we showed that enhanced cyclic AMP 
signaling in the b30 clone, by exposure to forskolin or 8-bromo-cyclic AMP, markedly enhances syncytia forma-
tion and hormonal differentiation, as reflected by elevated HCG synthesis and secretion16,20. We herein exploit the 
power of these two cell models to undertake an unbiased approach to identify genes, and gene products, which 
are coordinately regulated, either both up or both down, in the two cell systems that reflect human cytotropho-
blast fusion to syncytiotrophoblast.
Results
BeWo cells form syncytia upon forskolin treatment. BeWo cells grow in culture as cytotrophoblasts. 
Incubation with 100 µM forskolin for 72 h induces marked syncytia formation, as we have shown previously20 
(Fig. 1). In the absence of forskolin, cytotrophoblasts maintain a contiguous monolayer with prominent Z01 
staining at epithelial borders. No staining for hCGβ is detectable above background. In contrast, in the presence 
of forskolin for 72 h, there are abundant multi-nucleate syncytia, which show larger, clustered nuclei, display 
loss of Z01 staining, and exhibit abundant hCGβ staining within cytoplasmic vesicles, all compared to vehicle 
control BeWo cultures. Analysis of cell lysates and media during the 72 hour time course revealed essentially no 
detectable hCGβ in either cells or media in the absence of forskolin. Whereas a time-dependent accumulation of 
hCGβ was seen upon forskolin treatment (Fig. 2a). The total hCGβ synthesized (i.e. total media + cells) at 72 h in 
the presence of forskolin was ~5.4 × 104–fold greater than that seen at baseline in vehicle control treated cells in 
the absence of forskolin. Only the 35 kDa fully glycosylated form of hCGβ was detected in media, whereas in cell 
lysates both the 35 kDa fully glycosylated and the 24 kDa partially-glycosylated hCGβ forms were also detected. 
This is likely a consequence of such a marked induction in hCGβ synthesis and processing that the glycosylation 
machinery within the cells was overwhelmed (Fig. 2a,b).
RNA-Seq of BeWo cells and human placental trophoblasts. RNA-Seq was performed on triplicate 
cultures of BeWo cells at 0 h and 72 h in the absence of forskolin and at 24 h, 48 h, and 72 h in the presence of 
forskolin. As seen in Fig. 3a, there was a remarkable similarity in overall gene expression levels among the three 
samples at each of the time points. Moreover, there were minimal differences between the 0 h and 72 h samples in 
the absence of forskolin, whereas there were substantial differences among the 24 h, 48 h, and 72 h samples in the 
Figure 1. Triple-label immunofluorescence localization of BeWo cytotrophoblasts (left) and 
syncytiotrophoblasts (right). BeWo cells were treated with vehicle control (left) or with forskolin (right), and 
after 72 hours, cells were fixed, stained with DAPI (blue), anti-ZO1 (red), or anti-hCGβ (green), and imaged 
with an Olympus confocal microscope.
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presence of forskolin, relative to the vehicle-treated samples. A principal component analysis of these data is seen 
in Supplemental Fig. 1a and demonstrates the time course of the forskolin effect.
RNA-Seq was also performed on three male and three female placental cell cultures harvested at 24 h when the 
cytotrophoblast phenotype is >98% and 72 h when the syncytiotrophoblast phenotype is the most prominent. As 
seen in Fig. 3b, there was minor variation in the gene expression pattern among the three male and three female 
samples at 24 h. Similarly, there was minor variation in the expression patterns among the three male and three 
female samples at 72 h. However, there were substantial differences among the six 24 h (cytotrophoblast) samples, 
compared to the six 72 h (syncytiotrophoblast) samples. This pattern was exactly as anticipated, with the minor 
Figure 2. (a) Immunoblot analysis of hCGβ expression in media (M) and lysates (L) of BeWo cells treated with 
forskolin (+) or vehicle control (−) as described in Materials and Methods. The last column shows the total 
(media + lysate) increase in hCGβ expression compared to vehicle-treated control. (Column values are adjusted 
based on sample volumes analyzed). (b) Immunoblot analysis of hCGβ expression in BeWo cells treated with 
forskolin (+) or vehicle control (−) as well as human villous placental extract (hPL) with (T) and without (U) 
deglycosylation treatment. In both samples, deglycosylation produced the 18 kDa band predicted by the amino 
acid sequence of hCGβ.
Figure 3. RNA-Seq gene expression heat maps of triplicate samples for BeWo cells +/− forskolin. (a) Three 
independent female (a,b,c) and three independent male (d,e,f) samples of human term villous cytotrophoblasts 
and the syncytiotrophoblasts that evolve in vitro. (b) In each plot, the arrowhead denotes the sample used to 
order the heat map. Each letter denotes the same placental sample at a given time point.
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differences between samples at the same time point representing the variability present in genetically distinct 
samples. In contrast, the much larger differences in the same sample between time points captures the different 
transcriptional programs in place in cytotrophoblasts and syncytiotrophoblasts. A principal component analysis 
of these data is seen in Supplemental Fig. 1b and demonstrates the overlap of male and female samples at 24 h and 
at 72 h, yet distinction between all cytotrophoblast (24 h) and all syncytiotrophoblast (72 h) samples.
To determine the genes differentially expressed in the BeWo cells + forskolin (i.e. syncytiotrophoblasts) vs. 
the BeWo cells – forskolin (i.e. cytotrophoblasts), we analyzed the 50 most highly expressed genes in BeWo 
cells + forskolin and compared them to BeWo cells – forskolin and to the primary cells’ syncytiotrophoblast 
and cytotrophoblast models. A number of the most highly expressed genes during the BeWo transition from 
cytotrophoblast to syncytiotrophoblast was in the HCG family, including CG α and CG β, but three other 
highly expressed gene groups encoded histone variants, transcriptional elongation factors, and cytoskeletal 
proteins (Fig. 4a; Supplemental Table 1). Importantly, primary cells transitioning from the cytotrophoblast to 
syncytiotrophoblast phenotype also exhibited the most highly expressed genes within the HCG family mem-
bers, along with several transcriptional elongation factors. Interestingly, there were no histone variants among 
the top 50 most highly expressed genes between the two models of the villous trophoblast phenotypes (Fig. 4b; 
Supplemental Table 2). Instead, primary cells expressed several members of the cytochrome oxidase gene family. 
These differences between the two model systems demonstrate that there are distinct similarities, and differences, 
to the formation of syncytia in these two models that would be undetected without the direct comparison of 
choriocarcinoma-derived BeWo cells and primary human trophoblasts. Encouragingly, many of the genes in the 
cytotrophoblast to syncytiotrophoblast transition in both BeWo cells and primary human trophoblast cells over-
lap. This lends support to the use of both of these models and suggests that, despite some interesting differences, 
both are capturing important and shared aspects of the syncytialization process.
We next sought to rigorously characterize the pathways and gene families in our samples by using Panther21 
to perform a pathway analysis of the changes in gene expression in the BeWo cells +/− forskolin and the primary 
cells that transitioned from cytotrophoblast to syncytiotrophoblast. The gene ontology terms that were signif-
icantly enriched in our genes included sex differentiation, reproduction, tissue development and amino acid 
transport. These pathways are consistent with our understanding of the syncytialization process and yield insights 
into the cellular functions that are required for this transition. A complete list of significant pathways is included 
in Supplemental Table 3.
To best capture the genes that are critical in syncytialization, we combined our datasets into a joint analysis. To 
do this, we first stringently filtered each dataset independently, keeping only genes that were expressed inx ≥85th 
percentile for at least one-time point, while also showing greater than 2.5-fold change between the cytotroph-
oblast and syncytiotrophoblast. We subsequently plotted the genes as points determined on their fold change 
in human placenta syncytiotrophoblast/cytotrophoblast by their fold change in BeWo +/− forskolin (Fig. 5). 
Viewed this way, six genes were up-regulated under both conditions: HCGβ, TREML2, CRIP2, PAM, INHA and 
FLRG. Similarly, five genes were down-regulated under both conditions: SERPINF1, MMP19, C17orf96, KRT17 
and SAA1. We also performed a parallel analysis of our RNA-Seq data using two alternative pipelines (Cuffdiff 
and EdgeR) as described in Methods. We found that the genes that we selected for our focused analysis were 
indeed found to be differentially expressed in these analyses as well (Supplemental Tables 4 and 5). We selected 
this list of eleven genes for further analysis.
Figure 4. The most highly expressed genes in the BeWo cells (a) and human term primary villous 
cytotrophoblasts and their evolution to syncytiotrophoblasts in vitro (b). In each panel, the 50 most highly 
expressed genes in the indicated sample were selected and used to sort the heat map. The expression levels of 
those genes in each of the other samples is also shown.
www.nature.com/scientificreports/
5Scientific RepoRts |  (2018) 8:5142  | DOI:10.1038/s41598-018-23379-2
Protein expression in BeWo cells + /− forskolin and human placental trophoblasts. In order to 
determine if the changes in RNA levels (i.e. RNA-Seq expression) in BeWo cells + /− forskolin are reflected in the 
levels of the respective proteins, we performed quantitative Western blots of BeWo cells at 0, 24, 48 and 72 h + /− 
forskolin. Supplemental Table 6 lists the specific antibodies used for these analyses. As seen in Fig. 6 and Table 1 
for the six genes which are up-regulated, the increase in protein expression in cell lysates (Fig. 6) correlated with 
the increase in RNA in five of the six genes, INHA being the exception. Of note, the fold-change likely underesti-
mates overall protein synthesis and secretion for hCGβ, FLRG, PAM, INHA, which have secreted isoforms, as dis-
cussed above for HCGβ (Fig. 2). We also performed quantitative Western blots of human placental trophoblasts at 
24 h (cytotrophoblasts) and 72 h (syncytiotrophoblasts) as samples allowed. For hCGβ and TREML2 the increase 
in protein expression in cell lysates correlated with the increase in RNA (Supplementary Figure 2).
In addition to quantitative protein analyses in BeWo cells and human plancental trophoblasts, we examined 
normal human placental villi using immunostaining for each of the six proteins which were up-regulated. As seen 
in Supplemental Fig. 3, there is robust immunostaining in the villous syncytiotrophoblasts for hCGβ, TREML2, 
CRIP2, PAM and FLRG.
Similarly, changes in the protein and RNA expression for the five genes which are down-regulated were seen in 
Fig. 7 and Table 1. The decrease in RNA expression was relatively small for four (SERPINF1, MMPI9, C17orf96, 
KRT17). In three of these genes (MMP19, C17orf96, KRT17) there was minimal change in protein expression. 
Although SERPINF1 showed a decrease in RNA expression similar to these three genes, SERPINF1 showed the 
greatest decrease in protein expression. Among the down-regulated genes, the decrease in RNA expression for 
SAA1 was the greatest. Although SAA1 showed a significant decrease in protein expression, the diminished 
expression was not as great as the decrease in SERPINF1. As with the overexpressed proteins, several of these 
proteins (SERPINF1, SAA1, KRT17 and MMP19) are secreted and thus, our measured levels of protein expres-
sion may not reflect the entire spectrum of protein expression by the cells. From these analyses, we conclude that 
RNA-Seq closely reflect changes in protein abundance in these two models of human cytotrophoblast transition 
to syncytiotrophoblast.
Discussion
The data herein show a comprehensive, unbiased, RNA-Seq screen that identified genes which likely play a pivotal 
role in morphological and hormonal differentiation of cytotrophoblasts into syncytiotrophoblasts. The RNA-Seq 
analysis on samples from two complementary and biologically relevant in vitro model systems of syncytiali-
zation, including primary cultures of cytotrophoblasts transitioning to syncytiotrophoblasts from human term 
placentas derived from uncomplicated pregnancies, and forskolin-induced differentiation of cytotrophoblasts to 
syncytiotrophoblasts in the b30 clone of the human choriocarcinoma-derived cell line BeWo. We used stringent 
criteria to identify the most highly up-, and down-, regulated genes in the two model systems interrogated from 
the RNA-Seq data. We identified 11 genes from this analysis, with six up-regulated and five down-regulated, and 
pursued evaluation of protein expression of each of these in the BeWo system via quantitative Western blot anal-
ysis. The data show that the RNA and protein expression levels correlate closely, with the single exception being 
the expression of INHA. We speculate that this incongruence may reflect the fact that INHA is a secreted protein, 
and our analysis may therefore not reflect the actual expression of INHA.
Human chorionic gonadotropin is secreted by syncytiotrophoblasts and is a pivotal hormone for the mainte-
nance of pregnancy from implantation until delivery. Gonadotrophic glycoproteins such as HCG are composed of 
two subunits, a common α subunit and a protein specific β subunit. Whereas, increased production of hCGβ has 
been used as a surrogate for syncytialization by several investigators10,20,22, others urge caution with this notion 
as syncytial fusion and hCGβ production may well be independent23. Our results with hCGβ are an excellent 
indication that both of our cell models of trophoblast transition from mononuclear to multinuclear trophoblast 
are valid models of syncytialization.
Figure 5. The set of genes that are differentially expressed in both cell systems. Each gene that met our fold 
change and expression criteria was plotted by its fold change in transformation from term human placental 
cytotrophoblasts to syncytiotrophoblasts on the x-axis and the fold change in BeWo cells cultured without 
forskolin or with forskolin for 72 h, on the y-axis. Only genes that were up-regulated in both samples or down-
regulated in both samples were retained.
www.nature.com/scientificreports/
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The five upregulated genes are either secreted proteins or receptors. Peptidylglycine α-amidating monooxygen-
ase (PAM) is a bifunctional enzyme that catalyzes the amidation of bioactive peptides at the carboxy terminus to 
effect biological activity. Bioactive peptides include neurotransmitters, hormones, and paracrine signaling mole-
cules24. Cysteine –rich intestinal protein 2 (CRIP2), a LIM domain protein and transcription regulator, expressed 
Figure 6. (a) RNA-Seq analysis of up-regulated genes of interest in vehicle treated BeWo cells (−) or BeWo cells 
treated with forskolin (+) for the times described in Materials and Methods. Results are expressed in transcripts 
per million (TPM). Each bar represents the mean + /− SEM (n = 6). (b) Quantitative Western blot analysis of 
up-regulated genes of interest in vehicle treated BeWo cells (−) or BeWo cells treated with forskolin (+) for the 
times described in Materials and Methods. Immunoblots were quantified and normalized to levels of actin and 
subsequently to the 0h- sample of each blot.
www.nature.com/scientificreports/
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highly in the heart among numerous other tissues including the placenta, plays a role in development of each of 
these tissues25. Triggering receptor expressed on myeloid cells-like 2 (TRML2), also known as trem-like transcript 
2 (TLT-2), is a cell surface receptor that binds CD276 on T-cells and plays a role in T-cell activation during innate 
and adaptive immunity26. Follistatin-related gene (FLRG), also known as follistatin-like-3(FSTL-3), is a product 
of a member of the follistatin gene family and thus, has similar structure and function to that of follistatin. Human 
placental trophoblasts synthesize this protein during pregnancy, and human trophoblasts up-regulate expression 
of both the gene and protein product in response to hypoxia27. Notably, FLRG (FSTL-3) binds activin with high 
affinity to modulate endothelial cell proliferation and angiogenesis28. Activin is also produced in the placenta and 
is a well-known component of pregnancy screening for risk assessment of aneuploidy. Similar to FLRG, inhibin 
alpha (INHA) also modulates the effects of activin, as an antagonist to activin receptor binding29. Like activin, 
INHA is a member of the TGFβ superfamily, is one of the subunits of TGFβ, is part of activin A and activin AB, and 
is produced in human placental trophoblast30. The fact that both FLRG and INHA are produced in the placenta 
suggests that their up regulation is a result of, rather than a requirement for, syncytial formation. As with hCGβ, the 
relationship between the expression of these two proteins and syncytial formation requires further study.
RNA and protein expression of the down-regulated genes was not as consistently coordinated as that seen 
with the up-regulated genes; however, the two genes whose RNA expression is most down-regulated (i.e., SAA1 
and SERPINF1) also show the greatest reduction in protein expression. Elongin BC and Polycomb Repressive 
Complex 2-associated protein (EPOP, a.k.a. C17orf96) interact with multiple molecules to modulate chromatin 
configuration and to effect transcription in mammalian cells. C17orf96 generally up-regulates transcription, sug-
gesting this factor is key in the regulation of long-term developmental processes31. Pigment epithelium-derived 
factor (PEDF, a.k.a. SERPINF1), a multifunctional, non-inhibitory member of the serine protease inhibitor 
(SERPIN) superfamily, is a potent neurotrophic factor acting in the eye and spinal cord, is a potent inhibitor of 
angiogenesis32, and acts as a tumor suppressor via binding to high affinity ligands and cell-surface receptors33. 
Serum amyloid A1(SAA1), a serum protein precursor involved in the formation of amyloid A, is involved in high 
density lipoprotein remodeling, and may play a role in the regulation of inflammation and immunity34. Matrix 
metalloproteinase 19 (MMP19) is a member of a group of endopeptidases that degrade components of the extra-
cellular matrix during processes such as development and wound healing35. Keratin 17 (KTR17) is a type I keratin 
that participates in epidermal development and repair after tissue injury in mammals36, in part by promoting 
differentiation of selective epithelia37.
Taken together, we conclude that the activities of these eleven coordinately regulated gene products do not 
appear to behave as a single uniform function during the transition from mononucleated cytotrophoblast to 
differentiated syncytiotrophoblast. However, eight of the eleven proteins are secreted and are involved in cell 
signaling, either directly (INHA, hCGβ, FLRG, SERPINF1, SAA1) or indirectly by affecting signaling proteins 
or the extracellular matrix (PAM, MMP19, KRT17). Although the three remaining proteins are not secreted, two 
of them regulate transcription (CRIP2 and C17orf96) and one is a receptor (TREML2). The fact that all of these 
gene products are directly or indirectly involved in cell signaling remains consistent with the overall process of 
syncytial formation, which must involve cell-cell signaling given the nature of the fusion process.
Our RNA-Seq data was also examined for several other factors associated with cytotrophoblast fusion. 
Herein, both syncytin-1 and syncytin-2 were up-regulated in the presence of forskolin in BeWo cells whereas 
both were down-regulated in human placental syncytiotrophoblasts. By contrast, the transcript levels for 
the syncytin-1-receptor and syncytin-2 receptor, SLC1A5 and MFSD2A respectively, were largely static in 
vehicle-treated BeWo cells. Further, MFSD2A was expressed at very low levels (<1 TPM) at every time point 
regardless of forskolin treatment. In human placental samples, SLC1A5 was slightly up-regulated while MFSD2A 
was markedly up-regulated. Consistent with a critical role of GCMa38 in cyclic AMP-mediated syncytialization 
in BeWo cells, we observed an increase in GCMa transcript levels in the presence of forskolin that increased over 
Gene RNA Expression Protein Expression
Up-Regulated 72h− 72 h + Fractional Change 72h− 72 h+ Fractional Change
hCGβ 75 3500 47 0.49 64 130
FLRG 99 600 6.1 1.8 118 66
CRIP2 2.2 20 9.1 1.6 74 46
TREML2 3.7 130 35 0.97 35 36
PAM 4.3 12 2.8 1.5 6.1 4.1
INHA 5.8 170 29 0.94 0.92 0.98
Down-Regulated
SERPINF1 15 3.4 0.23 0.94 0.32 0.34
SAA1 11 0.50 0.05 0.57 0.26 0.46
C17orf96 9.4 2.4 0.26 0.62 0.44 0.71
KRT17 100 26 0.26 0.27 0.31 1.1
MMP19 72 25 0.35 0.38 0.57 1.5
Table 1. Summary of expression data from RNA-Seq and quantified immunoblot results shown in Figs 6 and 7.  
Data for 72 h vehicle control (−) or forskolin treated (+) cells are shown. Increases or decreases in expression 
are shown here as fractional change. Note in Fig. 5 that changes in RNA levels are expressed as -log2 fold 
change.
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time. However, there was effectively no change in the transcript levels of GCMa in human placental samples. 
TWIST139 was not expressed in BeWo cells at any timepoint, regardless of forskolin treatment, yet was consist-

















































































































































































































































Figure 7. (a) RNA-Seq analysis of down-regulated genes of interest in vehicle treated BeWo cells (−) or BeWo 
cells treated with forskolin (+) for the times described in Materials and Methods. Results are expressed in 
transcripts per million (TPM). (b) Quantitative Western blot analysis of down-regulated genes of interest in 
vehicle treated BeWo cells (−) or BeWo cells treated with forskolin (+) for the times described in Materials and 
Methods. Immunoblots were quantified and normalized to levels of actin and subsequently to the 0h- sample of 
each blot.
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ROCK1 and RAC140 were expressed at similar levels across all time points and treatments. Both LAT1 and 
4F2hc41 were upregulated 3–4 fold in forskolin-treated BeWo cells at 72 hours. In human placental cells, there was 
little change in transcript levels for these two genes. While we identified no change in Annexin-A542 transcript 
levels in either BeWo cells or human placental cytotrophoblast cultures during the process of syncytialization, 
this gene was among the top 5% of transcripts at all timepoints. In addition, we observed high expression of 
PLAC143 in syncytiotrophoblasts derived from human placental cells. This was the result of a greater than 5-fold 
up-regulation of this transcript from placental cytotrophoblasts. In contrast to the placenta samples, BeWo cells 
expressed only low levels at baseline, and down-regulated PLAC1 expression to less than one third of baseline 
with the addition of forskolin. Furthermore, there was no appreciable change in Galectin-111 expression in either 
BeWo cells or human placental samples. Finally, our RNA-Seq did not detect IKCa10 transcripts at any time point 
in any of our samples.
Gene expression changes in BeWo cells44–47, term human placental samples48, or JEG-3 cells co-cultured with 
human microvascular endothelial cells49 have been reported by other investigators. Via microarray analysis, 
Kudo et al.44 examined the changes in gene expression during BeWo trophoblast differentiation. Zheng et al.46  
performed RNA-Seq yielding data for BeWo cells of the parent choriocarcinoma cell line, to identify and cluster 
differentially expressed genes. Shankar and colleagues45 augmented their RNA-Seq data with DNA methylation 
and ChIP seq assays to generate a more complete epigenetic profile of BeWo cytotrophoblasts and syncyti-
otrophoblasts. Importantly, Rouault et al.48 employed microarrays to explore gene expression changes in vil-
lous cytotrophoblast and syncytiotrophoblasts in culture, and identified three transcriptional regulators (PPARγ, 
RARα, and NR2F1) of key importance to villous trophoblast differentiation. None of these three genes identified 
by Roualt et al.48 or of the thirteen genes identified by McConkey et al.49 were identified in our analysis of BeWo 
and human placental trophoblasts. McConkey et al.49 developed a novel method of syncytialization, by three 
dimensional co-culture of the choriocarcinoma JEG-3 line with human microvascular cells, in which JEG-3 cells 
form syncytia and assume gene expression changes similar to that seen in primary human syncytiotrophoblasts. 
In microarray analysis of BeWo cells + forskolin for 48 h, Renaud et al.47 identified OVOL1 as an up-regulated 
transcript and cognate protein and went on to demonstrate its role as a transcriptional regulator of trophoblast 
development. We also found OVOL1 up-regulated in BeWo + forskolin, however it was not up-regulated in the 
human placental cells and thus was not selected for further analysis. Our study is the first to use RNA-Seq to 
quantify gene expression in both primary human cytotrophoblasts and the syncytiotrophoblasts that evolve in 
culture. Moreover, we concurrently performed RNA-Seq on the BeWo b30 cell line, which was derived from the 
parent BeWo and which exhibits a marked capacity for syncytiotrophoblast formation in the presence of cyclic 
AMP stimulators. Comparing the commonalities and differences for the expressed genes between the two troph-
oblast phenotypes, and between our two models, allows us to better understand mediators that are pivotal in 
trophoblast syncytium formation. Moreover, our pursuit of changes in protein expression levels of differentially 
expressed genes buttresses the roles that these genes play in trophoblast differentiation.
Materials and Methods
Cells and Culture. BeWo b30 cells were cultured in F-12K Nutrient Mix, Kaighn’s Modification (Gibco), 10% 
FBS and 2 mM glutamine20. At 10% confluency, media was replaced with fresh media containing either 1% DMSO 
(control) or 100 µM forskolin in 1% DMSO at 0 h, 24 h, or 48 h as indicated. At the appropriate time, cells, media 
or both were harvested for RNA, protein analysis or immunofluorescence as indicated.
Human placental cytotrophoblasts were isolated from term human placentas of uncomplicated pregnancies. 
This study was approved by the Institutional Review Board of Washington University School of Medicine (IRB 
#201101889) which allowed verbal consent as no patient data was obtained other than the knowledge that the 
placenta was from a normal, term pregnancy. Informed consent was obtained from all study participants. All 
methods were performed in accordance with the relevant guidelines and regulations as previously described50–52. 
Following isolation, cells were plated at 3 × 105 cells/cm2 and maintained in Dulbecco’s modified Eagle’s MEM 
containing 10% fetal calf serum, 20 mM HEPES pH 7.4, penicillin (100 u/ml), streptomycin (100 µg/ml) and fun-
gizone (0.25 µg/ml) in 5% CO2/air. At 48 h, >85% of cells are multinucleated syncytiotrophoblast, as described 
earlier53. At the appropriate time (24 h for cytotrophoblasts, 72 h for syncytiotrophoblasts) cells were harvested 
for RNA or protein analysis as indicated.
Human placental villous extracts were prepared from term placentas as described51. Briefly, five, 5 mm3 sam-
ples of villous tissue were removed ~2 cm from the cord insertion but within the chorion frondosum, avoiding 
the basal plate. The samples were washed in PBSc, a phosphate buffered saline solution (DPBS, Cellgro) sup-
plemented with 100 mM CaCl2 and 50 mM MgCl2 and homogenized in PBSc-containing 0.5% Igepal CA-630 
(Sigma), Complete Protease Inhibitor Cocktail (Roche), and 1 mM DTT, for at least 30 min54 at 4 °C, centrifuged 
for 10 min at 13,000 × g at 4 °C and the supernatant (“lysate”) stored at −20 °C.
Protein Analysis. For cellular protein analysis BeWo cells or human placental trophoblasts were rinsed in 
PBS at 4 °C and thereafter incubated for 20 min at 4 °C with fresh lysis buffer, followed by centrifugation (15 min 
at 13,000 × g at 4 °C) and the resultant supernatant was stored at −20 °C, as described previously54. Western 
blot analysis following SDS-PAGE was performed on aliquots and probed with antibodies as described in the 
text and Supplemental Table 6. Actin content was evaluated on each sample as a control and for normalization. 
Human placental villous extracts also served as a control. Western blots were developed with Pierce ECL Western 
Blotting Substrate or SuperSignal West Femto Maximum Sensitivity Substrate from Thermo Scientific and results 
were quantified as described previously54. Following normalization to actin, quantification of each protein was 
presented as amount relative to the corresponding zero-hour sample. In general, 2–3 independent analyses were 
performed for each protein.
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Media samples from BeWo cells were analyzed directly via Western blot as described previously20. Selected 
samples of cell lysate or media were treated directly with De-glycosylation Mix II from New England Biolabs 
under denaturing conditions.
Immunofluorescence Analysis. For immunofluorescence analysis and as described previously20,54 BeWo 
cells were seeded onto glass coverslips in six well dishes and treated with forskolin or DMSO as described above. 
Cells were then washed with PBSc, fixed with 4% paraformaldehyde and permeabilized in 1% Triton-X 100. 
After blocking in 1% BSA/PBSc, coverslips were immunostained with primary antibody to determine subcellular 
localization. After washing with PBSc, coverslips were incubated with the appropriate AlexaFluor 488 or 568 
secondary antibodies (Invitrogen/Molecular Probes) and DAPI and mounted using Mowiol containing 2.5% 1, 
4-diazo-bicyclo-[2.2.2]-octane (DABCO, Sigma). Images were captured using an Olympus FluoView 1000 con-
focal laser scanning microscope, and Olympus FV10-ASW software, Version 3.0.
Immunohistochemistry Analysis. For immunohistochemistry analysis, human placental villous tissue 
was harvested as described above, washed in PBSc, fixed in 4% paraformaldehyde and embedded in paraffin. 
Tissue sections were processed via standard histological techniques and immunostained with antibodies listed 
in Supplementary Table 6 followed by HRP-secondary antibodies, incubation with HRP substrate and H and E 
counterstain. Images were captured using a Zeiss Axioskop microscope with Zen software.
RNA-Seq. Total RNA was isolated from BeWo and human trophoblasts using the RNeasy Plus Mini Kit 
(Qiagen) according to the manufacturer’s instructions. QIAshredder was used for homogenization. The amount 
of total RNA extracted was quantified on a Nanodrop 2000 spectrophotometer and RNA quality and purity was 
further evaluated using an Aligent 2100 Bioanalyzer (Aligent Technologies, Santa Clara, CA, US). RNA-Seq was 
performed at the Genome Technology Access Center in the Department of Genetics at Washington University 
School of Medicine. Briefly, ribo-depleted libraries were prepared from the RNA, and samples were indexed and 
sequenced on an Illumina HiSeq. 2500. Sequencing results from this study have been deposited in the NCBI Short 
Read Archive under accession number PRJNA397241.
Raw reads were pseudo-aligned using kallisto version 0.42.4 using options “—single –b 10 –l 220 –s 20”55. 
Transcript abundance and initial differential expression analysis was performed using the sleuth package56 in R 
version 3.2.1.
Bioinformatic Analysis. All analyses were performed in R version 3.2.1. Transcript abundance was deter-
mined by sleuth and measured in transcripts per million (TPM). To determine which transcripts are differentially 
expressed, we applied a filter requiring a transcript to be expressed at or above the 85th percentile in at least 
one sample, and have a 2.5-fold change in expression between syncytiotrophoblast samples and cytotrophoblast 
samples. Parallel analyses to identify differentially expressed genes was performed as follows. Reads were aligned 
to the hg19 reference genome using STAR57. The featureCounts method of the subread58 package was used to 
determine the number of reads that aligned to each gene. Finally, differential gene expression was determined by 
comparing 72 + and 72− BeWo samples and comparing 24 h and 72 h primary placental samples using the EdgeR 
package in R59 and the Cuffdiff package60. To generate the heat maps, one sample was designated as the index 
and used to sort the transcripts. The transcript levels for every other sample were ordered according to this index 
sample and displayed as log(TPM).
Gene list enrichment was performed using the Panther21 online suite of tools. We provided a list of the most 
significant genes as input. The resulting gene ontology categories were reported. The default setting of the Panther 
analysis is to perform a Bonferroni correction for multiple test correction. Thus, the reported results are unlikely 
to be false positives.
Data Availability Statement. The sequencing results from this study have been deposited in the NCBI 
Short Read Archive under accession number PRJNA397241.
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